Sukumar S - Search Results

1

DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma.

Fackler MJ, McVeigh M, Evron E, Garrett E, Mehrotra J, Polyak K, Sukumar S, Argani P. Fackler MJ, et al. Among authors: sukumar s. Int J Cancer. 2003 Dec 20;107(6):970-5. doi: 10.1002/ijc.11508. Int J Cancer. 2003. PMID: 14601057

2

Careful histological confirmation and microdissection reveal telomerase activity in otherwise telomerase-negative breast cancers.

Carey LA, Hedican CA, Henderson GS, Umbricht CB, Dome JS, Varon D, Sukumar S. Carey LA, et al. Among authors: sukumar s. Clin Cancer Res. 1998 Feb;4(2):435-40. Clin Cancer Res. 1998. PMID: 9516933

3

Altered WAF1 genes do not play a role in abnormal cell cycle regulation in breast cancers lacking p53 mutations.

McKenzie KE, Siva A, Maier S, Runnebaum IB, Seshadri R, Sukumar S. McKenzie KE, et al. Among authors: sukumar s. Clin Cancer Res. 1997 Sep;3(9):1669-73. Clin Cancer Res. 1997. PMID: 9815858

4

Telomerase activity in ductal carcinoma in situ and invasive breast cancer.

Umbricht CB, Sherman ME, Dome J, Carey LA, Marks J, Kim N, Sukumar S. Umbricht CB, et al. Among authors: sukumar s. Oncogene. 1999 Jun 3;18(22):3407-14. doi: 10.1038/sj.onc.1202714. Oncogene. 1999. PMID: 10362362

5

High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer.

Ferguson AT, Evron E, Umbricht CB, Pandita TK, Chan TA, Hermeking H, Marks JR, Lambers AR, Futreal PA, Stampfer MR, Sukumar S. Ferguson AT, et al. Among authors: sukumar s. Proc Natl Acad Sci U S A. 2000 May 23;97(11):6049-54. doi: 10.1073/pnas.100566997. Proc Natl Acad Sci U S A. 2000. PMID: 10811911 Free PMC article.

6

Compromised HOXA5 function can limit p53 expression in human breast tumours.

Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E, Marks J, Sukumar S. Raman V, et al. Among authors: sukumar s. Nature. 2000 Jun 22;405(6789):974-8. doi: 10.1038/35016125. Nature. 2000. PMID: 10879542

7

Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation.

Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L, Weitzman SA, Korz D, Sukumar S. Loeb DM, et al. Among authors: sukumar s. Cancer Res. 2001 Feb 1;61(3):921-5. Cancer Res. 2001. PMID: 11221883

8

Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation.

Evron E, Umbricht CB, Korz D, Raman V, Loeb DM, Niranjan B, Buluwela L, Weitzman SA, Marks J, Sukumar S. Evron E, et al. Among authors: sukumar s. Cancer Res. 2001 Mar 15;61(6):2782-7. Cancer Res. 2001. PMID: 11289162

9

Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR.

Evron E, Dooley WC, Umbricht CB, Rosenthal D, Sacchi N, Gabrielson E, Soito AB, Hung DT, Ljung B, Davidson NE, Sukumar S. Evron E, et al. Among authors: sukumar s. Lancet. 2001 Apr 28;357(9265):1335-6. doi: 10.1016/s0140-6736(00)04501-3. Lancet. 2001. PMID: 11343741

10

Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer.

Umbricht CB, Evron E, Gabrielson E, Ferguson A, Marks J, Sukumar S. Umbricht CB, et al. Among authors: sukumar s. Oncogene. 2001 Jun 7;20(26):3348-53. doi: 10.1038/sj.onc.1204438. Oncogene. 2001. PMID: 11423985

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

549 results

Search Page

Filters